These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36594642)

  • 1. Bayesian design of multi-regional clinical trials with time-to-event endpoints.
    Bean NW; Ibrahim JG; Psioda MA
    Biometrics; 2023 Dec; 79(4):3586-3598. PubMed ID: 36594642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian joint models for multi-regional clinical trials.
    Bean NW; Ibrahim JG; Psioda MA
    Biostatistics; 2023 Sep; ():. PubMed ID: 37669215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian multiregional clinical trials using model averaging.
    Bean NW; Ibrahim JG; Psioda MA
    Biostatistics; 2023 Apr; 24(2):262-276. PubMed ID: 34296263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BEATS: Bayesian hybrid design with flexible sample size adaptation for time-to-event endpoints.
    Bi D; Liu M; Lin J; Liu R
    Stat Med; 2023 Dec; 42(30):5708-5722. PubMed ID: 37858287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Consistency of Treatment Response Across Regions-the LEADER Trial in Relation to the ICH E17 Guideline.
    Nielsen HK; DeChiaro S; Goldman B
    Front Med (Lausanne); 2021; 8():662775. PubMed ID: 34136501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bayesian basket trial design using a calibrated Bayesian hierarchical model.
    Chu Y; Yuan Y
    Clin Trials; 2018 Apr; 15(2):149-158. PubMed ID: 29499621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability-nonexchangeability method.
    Daniells L; Mozgunov P; Bedding A; Jaki T
    Stat Med; 2023 Oct; 42(24):4392-4417. PubMed ID: 37614070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the performance of Bayesian and restricted maximum likelihood estimation for stepped wedge cluster randomized trials with a small number of clusters.
    Grantham KL; Kasza J; Heritier S; Carlin JB; Forbes AB
    BMC Med Res Methodol; 2022 Apr; 22(1):112. PubMed ID: 35418034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empirical shrinkage estimator for consistency assessment of treatment effects in multi-regional clinical trials.
    Quan H; Li M; Shih WJ; Ouyang SP; Chen J; Zhang J; Zhao PL
    Stat Med; 2013 May; 32(10):1691-706. PubMed ID: 22855311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence Diagnostics of a Region of Interest in Multi-regional Clinical Trials.
    Kuribayashi K; Cao C
    Ther Innov Regul Sci; 2023 Mar; 57(2):220-226. PubMed ID: 36109434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing a Bayesian hierarchical model for a prospective individual patient data meta-analysis with continuous monitoring.
    Wu D; Goldfeld KS; Petkova E
    BMC Med Res Methodol; 2023 Jan; 23(1):25. PubMed ID: 36698073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of estimand framework to the design and analysis of multi-regional clinical trials.
    Niu C; Liang L; Fu R; Zhong W; Wang WWB
    J Biopharm Stat; 2024 Jun; ():1-17. PubMed ID: 38840476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alone, together: On the benefits of Bayesian borrowing in a meta-analytic setting.
    Harari O; Soltanifar M; Verhoek A; Heeg B
    Pharm Stat; 2023; 22(5):903-920. PubMed ID: 37321565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian multivariate probability of success using historical data with type I error rate control.
    Alt EM; Psioda MA; Ibrahim JG
    Biostatistics; 2022 Dec; 24(1):17-31. PubMed ID: 34981114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-regional clinical trial design and consistency assessment of treatment effects.
    Quan H; Mao X; Chen J; Shih WJ; Ouyang SP; Zhang J; Zhao PL; Binkowitz B
    Stat Med; 2014 Jun; 33(13):2191-205. PubMed ID: 24515845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bayesian group sequential design for randomized biosimilar clinical trials with adaptive information borrowing from historical data.
    Zhang W; Pan Z; Yuan Y
    J Biopharm Stat; 2022 May; 32(3):359-372. PubMed ID: 35679137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian cluster hierarchical model for subgroup borrowing in the design and analysis of basket trials with binary endpoints.
    Chen N; Lee JJ
    Stat Methods Med Res; 2020 Sep; 29(9):2717-2732. PubMed ID: 32178585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian adaptive basket trial design using model averaging.
    Psioda MA; Xu J; Jiang Q; Ke C; Yang Z; Ibrahim JG
    Biostatistics; 2021 Jan; 22(1):19-34. PubMed ID: 31107534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian clinical trial design using historical data that inform the treatment effect.
    Psioda MA; Ibrahim JG
    Biostatistics; 2019 Jul; 20(3):400-415. PubMed ID: 29547966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.